SBIR Award, $1M Investment Get ONL Therapeutics to Clinical Trials

Xconomy Detroit – 11/12/14 by Sarah Schmid ONL Therapeutics, a University of Michigan spin-out biopharmaceutical startup working on sight-preserving therapies for retinal diseases, announced today that it has won a $1.3 million Small Business Innovation Research (SBIR) Phase II award from the National Eye Institute.

Read the Article

Privacy Statement | Accessibility Statement | Terms of Use | Copyright All Rights Reserved ©2024